CG:600216 Zhejiang Medicine Co., Ltd

Zhejiang Medicine Co., Ltd. is principally engaged in the production and distribution of drugs and nourishments. The Company mainly provides nourishments for animals and human, pharmaceuticals, agents, raw materials, intermediate products and others. The Company’s products include synthetic vitamin E, natural vitamin E soft capsules, levofloxacin lactate tablets, Beta carotene, vancomycin hydrochloride for injection, progesterone soft capsules and teicoplanin for injection, among others. The Company distributes its products within domestic market and to overseas markets.

15.15 CNY
As of 01/28/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   14,293,545,984 CNY
Current dividend yield:   1.49%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy